Comments
Lupin on Friday launched Iron Isomaltoside 1000 in India under brand names Isofer and Jilazo.
The drugmaker acquired the exclusive rights to market and sell the injectable formulation from Denmark-based Pharmacosmos A/S.
The drug is currently marketed in 33 countries, including 21 EU nations, under the brand name Monofer. The market for iron injectable drugs in India is valued at ₹310 crore and is currently growing at 17 per cent y-o-y.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.